NCT02453581View on ClinicalTrials.gov

Effectiveness of OZ439 Against Early Plasmodium Falciparum Blood Stage Infection in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Malaria
Interventions
DRUG

OZ439

OZ439 Powder for Oral Suspension

Trial Locations (1)

QLD 4006

Q-Pharm, Herston

All Listed Sponsors
collaborator

Queensland Institute of Medical Research

OTHER

lead

Medicines for Malaria Venture

OTHER

NCT02453581 - Effectiveness of OZ439 Against Early Plasmodium Falciparum Blood Stage Infection in Healthy Volunteers | Biotech Hunter | Biotech Hunter